VIELA BIO
Summary
Viela Bio operates as a clinical-stage biotechnology company. The Company develops and commercializes therapeutics and medicines for the treatment of patients with autoimmune and severe inflammatory diseases. Viela Bio serves patients worldwide.
Deals Overview
Total Deals1
Valued Deals1
Total Value£2,263M
Avg. Deal Size£2,263M
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
No credit card required
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.
